§ Mr. Malcolm BruceTo ask the Secretary of State for Health what plans he has in respect of clinical trials for third generation progestogens for their metabolites. [5922]
1152W
§ Mr. Malone[holding answer 14 December 1995]: Any company or investigator wishing to conduct a clinical trial with third generation progestogens or their metabolites would have to apply to the Medicines Control Agency in accordance with the Medicines Act 1968 and would have to provide a justification for the use of third generation progestogens taking into account the recent advice of the Committee on Safety of Medicines.